in-PharmaTechnologist RSS

PharmaForm rolls out contract spray-drying service

gareth.macdonald@decisionnews.com — Thu, 05 Nov 2009 11:00:00 +0100

US CMO PharmaForm has added spray-drying to its contract offering to capture a share of the ever-present market for drug bioavailability enhancement.

New Jersey R&D sites vital, says Merck CEO

gareth.macdonald@decisionnews.com — Thu, 05 Nov 2009 11:00:00 +0100

US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark.

Abraxis dedicates nanobiologics site

nick.taylor@decisionnews.com — Thu, 05 Nov 2009 11:00:00 +0100

Abraxis Health has dedicated its manufacturing facility in Phoenix, Arizona, US which is the result of a $70m (€47m) investment to give the company the nanotech and biologics capacity needed for Abraxane production.

Catalent unveils ulta-sensitive melamine test for drugs

gareth.macdonald@decisionnews.com — Thu, 05 Nov 2009 11:00:00 +0100

US contract services firm Catalent has launched a new test service capable of detecting trace amounts of the toxic chemical melamine in pharmaceuticals.

SMS deal expands reach

nick.taylor@decisionnews.com — Thu, 05 Nov 2009 11:00:00 +0100

Particulate Systems (PS) and Surface Measurement Systems (SMS) have entered into a strategic collaboration drawing on their knowledge of using analytic equipment for the characterisation of particulate, porous and complex materials.

GSK and Pfizer launch ViiV Healthcare

gareth.macdonald@decisionnews.com — Wed, 04 Nov 2009 11:00:00 +0100

GSK and Pfizer have launched their HIV focused JV, ViiV Healthcare with the promise that it will undertake “relentless pursuit” of new drugs.

West laying off 100 staff

nick.taylor@decisionnews.com — Wed, 04 Nov 2009 11:00:00 +0100

West Pharmaceutical Services is laying off 100 staff as part of restructuring efforts after its third quarter results fell short of expectations, despite operating profit increasing by 45 per cent.

Genzyme targets BBB

nick.taylor@decisionnews.com — Wed, 04 Nov 2009 11:00:00 +0100

Genzyme is evaluating to-BBB’s G-Technology as part of a research collaboration aimed at developing treatments capable of crossing the blood-brain barrier (BBB).

ThermoSafe and Storopack form EU focused partnership

gareth.macdonald@decisionnews.com — Tue, 03 Nov 2009 11:00:00 +0100

Insulated packaging specialist ThermoSafe Brands has formed a supply partnership with German firm Storopack Hans Reichenecker in an effort to expand in Europe.

People on the move: pharma jobs

nick.taylor@decisionnews.com — Tue, 03 Nov 2009 11:00:00 +0100

in-PharmaTechnologist presents its latest roundup of movements in the pharma sector, including appointments at Intrexon, Cephalon, NeoPharma and Chelsea Therapeutics.